Aurobindo Pharma will catalize your investment surely
Scrip is at Rs 691 having risen handsomely with good volumes after a full fledged correction and hibernating for quite some time.
With USFDA behind it and a good number of ANDAs in the offing and due for sanction from USFDA in the coming year, it is sure to catapult to much newer heights.
Resistance being at Rs 725 ~ 750, a breather and then a sustained rise to Rs 1050+ cannot be ruled out.
Buy and hold with a stoploss of Rs. 665 or so.
With USFDA behind it and a good number of ANDAs in the offing and due for sanction from USFDA in the coming year, it is sure to catapult to much newer heights.
Resistance being at Rs 725 ~ 750, a breather and then a sustained rise to Rs 1050+ cannot be ruled out.
Buy and hold with a stoploss of Rs. 665 or so.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。